Icon partners with KoNECT to advance S. Korean clinical trials industry

Wednesday, October 3, 2012 10:43 AM

Icon, a global provider of outsourced development services, and Korea National Enterprise for Clinical Trials (KoNECT) have signed a partnership agreement that aims to advance the clinical trials industry in South Korea.

Icon and KoNECT will collaborate on a series of educational events for local and multinational pharmaceutical companies, investigators and industry officials. The programs aim to further enhance the already high standards of clinical research in South Korea and will kick off with an oncology trials seminar in Seoul on October 26.

“South Korea has become a key country for clinical development and Icon has had a well-established presence there since 2005,” said Wei Ming Goh, vice president, Asia-Pacific, Icon. “Our agreement with KoNECT supports our mutual interest in developing and growing the clinical research industry in South Korea and demonstrates our on-going commitment to the Asia Pacific region.” 

KoNECT president, Sang-Goo Shin, added, “We are delighted to collaborate with a leading clinical research organisation such as Icon that has a wealth of expertise in both local and global clinical development programs. Together we can develop high quality clinical research professionals and a clinical trials infrastructure that can support the increased demand from local and global pharma companies.”

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

August 25

Verizon Communications enters clinical trial space with technology, network, and cloud and data services

Sponsors look to the power of genomic profiling to screen, enroll patients in trials for targeted therapies

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

August

Reality of costs and impact rain on Sunshine Act
Concerns mount over compliance burden on CROs, sponsors, unanticipated consequences for research

Cloud computing expanding into all areas of clinical trial conduct
Benefits outweigh the complexities, challenges of finding right vendors

Already a subscriber?
Log in to your digital subscription.

Purchase the August issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

July

IRB market consolidating rapidly
Private equity driving a new commercial ethical review landscape

Lessons learned from medical device trials
Smaller, faster, more flexible trials hold important insights for pharmaceutical innovation

Already a subscriber?
Log in to your digital subscription.

Purchase the July issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs